Term	Overlap	P.value	Adjusted.P.value	Old.P.value	Old.Adjusted.P.value	Odds.Ratio	Combined.Score	Genes
Protein processing in endoplasmic reticulum	20/171	7.49986642353098e-08	1.79996794164744e-05	0	0	4.72218481840105	77.4711986033348	XBP1;SSR4;WFS1;DERL3;SEL1L;HSPA6;NGLY1;SSR3;EIF2AK3;SYVN1;RRBP1;EIF2AK4;HSP90B1;HERPUD1;ERLEC1;LMAN1;DDIT3;SIL1;HSPA1B;TXNDC5
B cell receptor signaling pathway	13/81	3.79601914180614e-07	4.55522297016737e-05	0	0	6.75780914555603	99.9084149337669	LYN;CR2;JUN;CD72;FOS;CD79B;CD79A;CD19;BLNK;BTK;PLCG2;FCGR2B;CD22
Hematopoietic cell lineage	12/99	2.11821502583931e-05	0.00169457202067145	0	0	4.86200615539225	52.326620211337	FCER2;CR2;HLA-DMA;CD19;CD37;ITGA6;CD24;HLA-DOB;MS4A1;CD22;CD55;HLA-DQB1
Intestinal immune network for IgA production	7/48	0.000357243768718919	0.0214346261231351	0	0	5.97807519591441	47.4485339108284	CD40;HLA-DMA;CXCR4;TNFRSF17;TNFRSF13C;HLA-DOB;HLA-DQB1
Primary immunodeficiency	6/38	0.000609798179100636	0.0292703125968305	0	0	6.55641891891892	48.5331207301934	CD79A;CD40;CD19;BLNK;BTK;TNFRSF13C
Cell adhesion molecules	12/148	0.000969064927545759	0.0387625971018304	0	0	3.10237865638058	21.5279606475141	CNTNAP2;CD40;HLA-DMA;CADM1;CLDN14;ICAM2;SDC1;ITGA6;HLA-DOB;CD22;HLA-DQB1;JAM3
Allograft rejection	5/38	0.00398477347351395	0.126304468318677	0	0	5.28831480270329	29.2193925833592	CD40;HLA-DMA;IL12A;HLA-DOB;HLA-DQB1
Toxoplasmosis	9/112	0.00429521362724137	0.126304468318677	0	0	3.06078514140988	16.6820564178509	LAMA5;CD40;HLA-DMA;HSPA6;IL12A;ITGA6;HLA-DOB;HSPA1B;HLA-DQB1
Epstein-Barr virus infection	13/202	0.0047364175619504	0.126304468318677	0	0	2.4161935658286	12.9326137659383	LYN;JUN;CD40;CDKN1A;CR2;FCER2;HLA-DMA;CD19;BTK;PLCG2;BLNK;HLA-DOB;HLA-DQB1
Leishmaniasis	7/77	0.00581851732520435	0.128229753898691	0	0	3.49620938628159	17.9939751280579	HLA-DMA;JUN;NCF1;IL12A;FOS;HLA-DOB;HLA-DQB1
Fluid shear stress and atherosclerosis	10/139	0.00587719705369002	0.128229753898691	0	0	2.71669550781525	13.9547827731284	MEF2C;JUN;NCF1;DUSP1;CAV1;SDC1;FOS;SQSTM1;KLF2;HSP90B1
Viral myocarditis	6/60	0.00658797994716482	0.131759598943296	0	0	3.88088088088088	19.4917572525153	CD40;HLA-DMA;CAV1;HLA-DOB;CD55;HLA-DQB1
Lipid and atherosclerosis	13/215	0.0078824159769152	0.145521525727665	0	0	2.25916925634169	10.941429674956	LYN;JUN;XBP1;CD40;NCF1;HSPA6;EIF2AK3;FOS;POU2F2;HSP90B1;DDIT3;IL12A;HSPA1B
Osteoclast differentiation	9/127	0.00960999665718067	0.164742799837383	0	0	2.66962969786293	12.4003002128427	JUN;NCF1;BTK;PLCG2;BLNK;FOS;FCGR2B;JUNB;SQSTM1
Asthma	4/31	0.0105697322871319	0.16911571659411	0	0	5.16310924928519	23.4909121048305	CD40;HLA-DMA;HLA-DOB;HLA-DQB1
Leukocyte transendothelial migration	8/114	0.0150145355500443	0.225218033250665	0	0	2.63850694325975	11.0783954356699	NCF1;CLDN14;PLCG2;RHOH;CXCR4;PTK2B;EZR;JAM3
Autoimmune thyroid disease	5/53	0.0161886008416301	0.228544953058308	0	0	3.63290617505995	14.9800994698651	CD40;HLA-DMA;CGA;HLA-DOB;HLA-DQB1
Pertussis	6/76	0.0198267211103882	0.251625899012054	0	0	2.99135135135135	11.7282651298533	C4A;JUN;CFL2;IRF8;IL12A;FOS
Chemokine signaling pathway	11/192	0.0199203836717876	0.251625899012054	0	0	2.12795580110497	8.33309995546208	LYN;NCF1;GNG7;PLCG2;CXCR5;GNB3;CXCR4;PTK2B;CCR7;GNB5;RASGRP2
Antigen processing and presentation	6/78	0.0222412492004413	0.266894990405296	0	0	2.90795795795796	11.0671257113224	CD74;HLA-DMA;HSPA6;HLA-DOB;HSPA1B;HLA-DQB1
Type I diabetes mellitus	4/43	0.0319115125238671	0.364703000272767	0	0	3.57225060995258	12.3056476064222	HLA-DMA;IL12A;HLA-DOB;HLA-DQB1
Inflammatory bowel disease	5/65	0.0355620712298114	0.387949867961579	0	0	2.90452637889688	9.69088146238176	HLA-DMA;JUN;IL12A;HLA-DOB;HLA-DQB1
Measles	8/139	0.0423483717023922	0.435867998792709	0	0	2.13221429261626	6.74168911078688	JUN;HSPA6;EIF2AK3;IL12A;EIF2AK4;FOS;FCGR2B;HSPA1B
Th1 and Th2 cell differentiation	6/92	0.0447510018733156	0.435867998792709	0	0	2.43280955373979	7.5578669905573	HLA-DMA;JUN;IL12A;FOS;HLA-DOB;HLA-DQB1
Human T-cell leukemia virus 1 infection	11/219	0.0454029165409072	0.435867998792709	0	0	1.84913461538462	5.71785510568837	JUN;CD40;CDKN1A;KAT2A;HLA-DMA;CREB3L2;TNFRSF13C;FOS;HLA-DOB;SLC25A4;HLA-DQB1
Fc gamma R-mediated phagocytosis	6/97	0.0553252824469836	0.510694914895233	0	0	2.2985446985447	6.65319575513518	LYN;NCF1;CFL2;PLCG2;PIP5K1B;FCGR2B
NF-kappa B signaling pathway	6/104	0.0724593977926653	0.644083535934803	0	0	2.13359073359073	5.60009726870761	LYN;CD40;BTK;PLCG2;BLNK;TNFRSF13C
Graft-versus-host disease	3/42	0.113073842121159	0.938058997991891	0	0	2.67438654535429	5.82939833879782	HLA-DMA;HLA-DOB;HLA-DQB1
Rheumatoid arthritis	5/93	0.120498147198897	0.938058997991891	0	0	1.97749754741661	4.1846238939643	HLA-DMA;JUN;FOS;HLA-DOB;HLA-DQB1
Staphylococcus aureus infection	5/95	0.128613894784797	0.938058997991891	0	0	1.93335331734612	3.96519247720886	C4A;HLA-DMA;FCGR2B;HLA-DOB;HLA-DQB1
Epithelial cell signaling in Helicobacter pylori infection	4/70	0.133378893926362	0.938058997991891	0	0	2.10793754420325	4.24656955633062	LYN;JUN;PLCG2;JAM3
Protein export	2/23	0.135149496964627	0.938058997991891	0	0	3.30828861061419	6.62112191098003	SPCS2;SEC11C
Circadian entrainment	5/97	0.13697158677568	0.938058997991891	0	0	1.89112840162652	3.75952878803543	PER1;GNG7;GNB3;GNB5;FOS
Human immunodeficiency virus 1 infection	9/212	0.143191736741985	0.938058997991891	0	0	1.54497751124438	3.00277307003689	JUN;CFL2;GNG7;PLCG2;CXCR4;GNB3;PTK2B;FOS;GNB5
Vitamin digestion and absorption	2/24	0.144828200182317	0.938058997991891	0	0	3.15774922751667	6.10142536801767	SLC5A6;LMBRD1
p53 signaling pathway	4/73	0.148710802064965	0.938058997991891	0	0	2.01597585408373	3.8419495820587	CDKN1A;RRM2B;SESN1;IGF1
Relaxin signaling pathway	6/129	0.155046117425425	0.938058997991891	0	0	1.6977367611514	3.1646367955535	JUN;GNG7;CREB3L2;GNB3;GNB5;FOS
Longevity regulating pathway	5/102	0.158868028845703	0.938058997991891	0	0	1.79318400949344	3.29888732045018	SESN1;CREB3L2;HSPA6;IGF1;HSPA1B
Malaria	3/50	0.164823006416332	0.938058997991891	0	0	2.21825669183253	3.99925743286527	CD40;SDC1;IL12A
N-Glycan biosynthesis	3/50	0.164823006416332	0.938058997991891	0	0	2.21825669183253	3.99925743286527	ST6GAL1;MGAT5;ALG13
Transcriptional misregulation in cancer	8/192	0.1728984929778	0.938058997991891	0	0	1.51387687711298	2.65693052525782	MEF2C;CD40;CDKN1A;DDIT3;ZBTB16;IGF1;PAX5;CDK14
Kaposi sarcoma-associated herpesvirus infection	8/193	0.176291731042279	0.938058997991891	0	0	1.50561556131176	2.61316909313792	LYN;JUN;CDKN1A;GNG7;PLCG2;GNB3;FOS;GNB5
Parathyroid hormone synthesis, secretion and action	5/106	0.177339902219554	0.938058997991891	0	0	1.72181067027566	2.9781935955165	MEF2C;CDKN1A;CREB3L2;PDE4B;FOS
Th17 cell differentiation	5/107	0.18208033335405	0.938058997991891	0	0	1.70484200874594	2.90386983412964	JUN;HLA-DMA;FOS;HLA-DOB;HLA-DQB1
Apelin signaling pathway	6/137	0.187710496485827	0.938058997991891	0	0	1.5933979781308	2.66552284311822	MEF2C;MEF2B;GNG7;GNB3;GNB5;KLF2
Estrogen signaling pathway	6/137	0.187710496485827	0.938058997991891	0	0	1.5933979781308	2.66552284311822	JUN;CREB3L2;HSPA6;FOS;HSPA1B;HSP90B1
HIF-1 signaling pathway	5/109	0.191699275469251	0.938058997991891	0	0	1.67188364692861	2.76166323172065	CDKN1A;MKNK2;PLCG2;IGF1;PDK1
PI3K-Akt signaling pathway	13/354	0.19728817813307	0.938058997991891	0	0	1.32860628893122	2.1564472971524	LAMA5;CDKN1A;IGF1;HSP90B1;NR4A1;TCL1A;CD19;GNG7;CREB3L2;GNB3;COL9A3;ITGA6;GNB5
MAPK signaling pathway	11/294	0.205289603357316	0.938058997991891	0	0	1.35378091872792	2.14348681222301	NR4A1;MEF2C;JUN;DUSP1;DDIT3;HSPA6;MKNK2;IGF1;FOS;RASGRP2;HSPA1B
TNF signaling pathway	5/112	0.20645337509385	0.938058997991891	0	0	1.62475626975055	2.56334657413048	JUN;CASP10;CREB3L2;FOS;JUNB
Cholinergic synapse	5/113	0.211452981692494	0.938058997991891	0	0	1.60962896349587	2.50096520958991	GNG7;CREB3L2;GNB3;GNB5;FOS
Legionellosis	3/57	0.214677154335924	0.938058997991891	0	0	1.9300079649542	2.96954883021245	HSPA6;IL12A;HSPA1B
Circadian rhythm	2/31	0.215640919315559	0.938058997991891	0	0	2.39467028560854	3.6737610649266	PER1;BHLHE41
ErbB signaling pathway	4/85	0.215849202294936	0.938058997991891	0	0	1.71624886406454	2.63131028574309	CDKN1A;JUN;GAB1;PLCG2
Taste transduction	4/86	0.22178779941417	0.938058997991891	0	0	1.69523142269125	2.55307652106566	SCNN1B;GNB3;SCN3A;TAS1R3
Calcium signaling pathway	9/240	0.233433702368359	0.938058997991891	0	0	1.35573122529644	1.97239529654736	CYSLTR1;P2RX5;P2RX1;ORAI2;PLCG2;ATP2A3;CXCR4;PTK2B;SLC25A4
ECM-receptor interaction	4/88	0.233790408852693	0.938058997991891	0	0	1.65469778575703	2.4048223526998	LAMA5;SDC1;ITGA6;COL9A3
Pathways in cancer	18/531	0.237313525256375	0.938058997991891	0	0	1.22296533229944	1.75908046155162	LAMA5;JUN;CDKN1A;ZBTB16;PTCH2;CXCR4;FOS;IGF1;RASGRP2;HSP90B1;GNG7;PLCG2;CCDC6;GNB3;ITGA6;IL12A;PIM2;GNB5
GABAergic synapse	4/89	0.239850019511254	0.938058997991891	0	0	1.63514626676523	2.33456613406352	GNG7;GNB3;GNB5;SLC38A5
Growth hormone synthesis, secretion and action	5/119	0.242213277425262	0.938058997991891	0	0	1.52443834406159	2.16155696712072	CREB3L2;PLCG2;IGF1;FOS;JUNB
Neurotrophin signaling pathway	5/119	0.242213277425262	0.938058997991891	0	0	1.52443834406159	2.16155696712072	JUN;PRDM4;MAGED1;PLCG2;GAB1
Tuberculosis	7/180	0.242331907814572	0.938058997991891	0	0	1.40712839882306	1.99452988897806	CD74;HLA-DMA;CASP10;IL12A;FCGR2B;HLA-DOB;HLA-DQB1
Morphine addiction	4/91	0.252074931810448	0.960285454515992	0	0	1.59739160940176	2.20125178195184	GNG7;PDE4B;GNB3;GNB5
Mucin type O-glycan biosynthesis	2/36	0.267866465561151	0.977740908289777	0	0	2.04198674102915	2.68984110614341	ST6GALNAC3;ST6GALNAC4
Platelet activation	5/124	0.268696640820821	0.977740908289777	0	0	1.46000846381718	1.91870262986647	LYN;P2RX1;BTK;PLCG2;RASGRP2
Endocytosis	9/252	0.277315669165016	0.977740908289777	0	0	1.28797638217928	1.65195699025347	SNX2;CAV1;HSPA6;CHMP4C;CXCR4;PIP5K1B;VPS37B;SMAP2;HSPA1B
Aldosterone-regulated sodium reabsorption	2/37	0.278340162419353	0.977740908289777	0	0	1.98354203935599	2.53677434295859	SCNN1B;IGF1
Thyroid cancer	2/37	0.278340162419353	0.977740908289777	0	0	1.98354203935599	2.53677434295859	CDKN1A;CCDC6
Prostate cancer	4/97	0.289440951562646	0.977740908289777	0	0	1.49387077469547	1.85210691674838	CDKN1A;CREB3L2;IGF1;HSP90B1
Choline metabolism in cancer	4/98	0.295747436297975	0.977740908289777	0	0	1.47790213529929	1.80045345555774	JUN;SLC44A2;PIP5K1B;FOS
Fc epsilon RI signaling pathway	3/68	0.297842990865665	0.977740908289777	0	0	1.60248138957816	1.94090752346765	LYN;BTK;PLCG2
Mitophagy	3/68	0.297842990865665	0.977740908289777	0	0	1.60248138957816	1.94090752346765	JUN;EIF2AK3;SQSTM1
Hepatitis B	6/162	0.303142636133143	0.977740908289777	0	0	1.33631323631324	1.59495911924523	JUN;CDKN1A;CASP10;CREB3L2;PTK2B;FOS
Amphetamine addiction	3/69	0.305544033840555	0.977740908289777	0	0	1.57811990876507	1.87111581904688	JUN;CREB3L2;FOS
Renal cell carcinoma	3/69	0.305544033840555	0.977740908289777	0	0	1.57811990876507	1.87111581904688	CDKN1A;JUN;GAB1
Dopaminergic synapse	5/132	0.312232906089223	0.985998650808071	0	0	1.36747295077324	1.59174654967698	GNG7;CREB3L2;GNB3;GNB5;FOS
Coronavirus disease	8/232	0.326857032550487	0.99783448486763	0	0	1.24095840867993	1.38767991578876	C4A;JUN;RPL18A;RPS8;RPS5;PLCG2;IL12A;FOS
Systemic lupus erythematosus	5/135	0.328811898845595	0.99783448486763	0	0	1.33570835639181	1.48566756920716	C4A;CD40;HLA-DMA;HLA-DOB;HLA-DQB1
Toll-like receptor signaling pathway	4/104	0.333876469359156	0.99783448486763	0	0	1.38879712746858	1.52348851505411	JUN;CD40;IL12A;FOS
Focal adhesion	7/201	0.33462196094484	0.99783448486763	0	0	1.25344262905207	1.37221115538501	LAMA5;JUN;CAV1;PIP5K1B;COL9A3;ITGA6;IGF1
Glioma	3/75	0.351802848017784	0.99783448486763	0	0	1.44616188769415	1.51078269330663	CDKN1A;PLCG2;IGF1
Thyroid hormone synthesis	3/75	0.351802848017784	0.99783448486763	0	0	1.44616188769415	1.51078269330663	CREB3L2;CGA;HSP90B1
Proteoglycans in cancer	7/205	0.352834542298032	0.99783448486763	0	0	1.22786529555483	1.27913610100805	CDKN1A;CAV1;PLCG2;GAB1;SDC1;IGF1;EZR
Glycosphingolipid biosynthesis	2/45	0.361162840633538	0.99783448486763	0	0	1.61384532179557	1.64358258483624	ST6GALNAC3;ST6GALNAC4
Apoptosis	5/142	0.367767151931709	0.99783448486763	0	0	1.26700099774195	1.26738778830475	JUN;CASP10;DDIT3;EIF2AK3;FOS
Carbohydrate digestion and absorption	2/47	0.381374939365466	0.99783448486763	0	0	1.54195984893659	1.4864065742764	SLC2A5;TAS1R3
Selenocompound metabolism	1/17	0.383601127484972	0.99783448486763	0	0	2.16774553571429	2.07702971350508	CTH
Serotonergic synapse	4/113	0.391334786227366	0.99783448486763	0	0	1.27353285128391	1.19481814763077	DUSP1;GNG7;GNB3;GNB5
Amino sugar and nucleotide sugar metabolism	2/48	0.391379106737947	0.99783448486763	0	0	1.50836120401338	1.41496137604011	GMPPB;PGM3
Other glycan degradation	1/18	0.400905793895327	0.99783448486763	0	0	2.04012605042017	1.86473398043846	MANBA
Cocaine addiction	2/49	0.401309875948045	0.99783448486763	0	0	1.47619228866136	1.34779513843647	JUN;CREB3L2
Sphingolipid metabolism	2/49	0.401309875948045	0.99783448486763	0	0	1.47619228866136	1.34779513843647	ARSA;CERS4
cAMP signaling pathway	7/216	0.403289925263732	0.99783448486763	0	0	1.1625757863645	1.05573455793014	JUN;CREB3L2;ATP2A3;PDE4B;OXT;FOS;CGA
Vibrio cholerae infection	2/50	0.4111634925786	0.99783448486763	0	0	1.44536374478235	1.28458777120063	PLCG2;KDELR3
Ovarian steroidogenesis	2/51	0.420936469935901	0.99783448486763	0	0	1.41579350881676	1.22504840566394	IGF1;CGA
Phagosome	5/152	0.423411951364941	0.99783448486763	0	0	1.18019869818431	1.01427420153969	HLA-DMA;NCF1;FCGR2B;HLA-DOB;HLA-DQB1
Complement and coagulation cascades	3/85	0.42779768573302	0.99783448486763	0	0	1.26914503015998	1.07763725381988	C4A;CR2;CD55
One carbon pool by folate	1/20	0.43407379243547	0.99783448486763	0	0	1.82518796992481	1.5231937020527	ALDH1L2
Steroid biosynthesis	1/20	0.43407379243547	0.99783448486763	0	0	1.82518796992481	1.5231937020527	SC5D
Oxytocin signaling pathway	5/154	0.434457769240536	0.99783448486763	0	0	1.164236396118	0.970573277490671	MEF2C;JUN;CDKN1A;OXT;FOS
Colorectal cancer	3/86	0.435243823657818	0.99783448486763	0	0	1.2537893509522	1.04296328084498	CDKN1A;JUN;FOS
Non-alcoholic fatty liver disease	5/155	0.439963803346701	0.99783448486763	0	0	1.15641486810552	0.949489253361493	JUN;XBP1;DDIT3;EIF2AK3;FOS
Thyroid hormone signaling pathway	4/121	0.4418083157046	0.99783448486763	0	0	1.18596265095367	0.968788181034428	KAT2A;THRB;PLCG2;ATP2A3
Human cytomegalovirus infection	7/225	0.44451748385564	0.99783448486763	0	0	1.11405789421389	0.903240141276103	CDKN1A;GNG7;CREB3L2;CXCR4;GNB3;PTK2B;GNB5
Cellular senescence	5/156	0.445457342920772	0.99783448486763	0	0	1.14869693649054	0.928898128584074	CDKN1A;E2F5;SQSTM1;SLC25A4;ZFP36L2
Hypertrophic cardiomyopathy	3/90	0.46464701626869	0.99783448486763	0	0	1.19589667531825	0.916627614665626	ATP2A3;ITGA6;IGF1
Ras signaling pathway	7/232	0.476252207918878	0.99783448486763	0	0	1.07900521460088	0.800414394336653	GNG7;PLCG2;GAB1;GNB3;IGF1;GNB5;RASGRP2
Glutathione metabolism	2/57	0.477716425459944	0.99783448486763	0	0	1.26095300048788	0.93151386578521	RRM2B;CHAC1
Small cell lung cancer	3/92	0.479095736852864	0.99783448486763	0	0	1.1689017760058	0.860142021612602	LAMA5;CDKN1A;ITGA6
Mannose type O-glycan biosynthesis	1/23	0.480420349359766	0.99783448486763	0	0	1.57605519480519	1.15539633979701	LARGE2
Renin-angiotensin system	1/23	0.480420349359766	0.99783448486763	0	0	1.57605519480519	1.15539633979701	KLK1
Lysosome	4/128	0.484917482323942	0.99783448486763	0	0	1.11860774888516	0.809622048407707	GGA2;ARSA;MANBA;LAPTM5
GnRH signaling pathway	3/93	0.48625137933261	0.99783448486763	0	0	1.15585424133811	0.833405060468991	JUN;PTK2B;CGA
IL-17 signaling pathway	3/94	0.49335930533156	0.99783448486763	0	0	1.14309346567411	0.807615602031131	JUN;FOS;HSP90B1
Notch signaling pathway	2/59	0.4958780464107	0.99783448486763	0	0	1.21658349810125	0.85334239240544	KAT2A;TLE1
Prion disease	8/273	0.500309799183477	0.99783448486763	0	0	1.04672284963663	0.724884645121629	NCF1;DDIT3;CAV1;CREB3L2;HSPA6;EIF2AK3;SLC25A4;HSPA1B
Long-term depression	2/60	0.504806913812818	0.99783448486763	0	0	1.19554623403862	0.817250623955276	LYN;IGF1
cGMP-PKG signaling pathway	5/167	0.504814836985373	0.99783448486763	0	0	1.07008837374545	0.731473435797622	MEF2C;MEF2B;CREB3L2;ATP2A3;SLC25A4
Viral carcinogenesis	6/203	0.506269104042274	0.99783448486763	0	0	1.05594731787625	0.718769532654817	LYN;JUN;CDKN1A;KAT2A;CREB3L2;HDAC9
Dilated cardiomyopathy	3/96	0.507426704953113	0.99783448486763	0	0	1.1183951901954	0.75872265471264	ATP2A3;ITGA6;IGF1
Tight junction	5/169	0.515348033265081	0.99783448486763	0	0	1.05692884716617	0.700651676077977	JUN;CLDN14;EZR;YBX3;JAM3
Inflammatory mediator regulation of TRP channels	3/98	0.521287992914549	0.99783448486763	0	0	1.09473684210526	0.713169184481539	PLCG2;TRPV3;IGF1
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	1/26	0.522977551502566	0.99783448486763	0	0	1.38671428571429	0.898891411372367	PIGB
Basal cell carcinoma	2/63	0.530969383516768	0.99783448486763	0	0	1.13657292002698	0.719508529900344	CDKN1A;PTCH2
Influenza A	5/172	0.530969917704919	0.99783448486763	0	0	1.03778055399991	0.656966887867575	HLA-DMA;IL12A;HLA-DOB;SLC25A4;HLA-DQB1
Viral protein interaction with cytokine and cytokine receptor	3/100	0.5349342547951	0.99783448486763	0	0	1.07205409599823	0.670689293752368	CXCR5;CXCR4;CCR7
Yersinia infection	4/137	0.53824937757148	0.99783448486763	0	0	1.04242653311915	0.645713706512011	JUN;PTK2B;PIP5K1B;FOS
GnRH secretion	2/64	0.539478514854388	0.99783448486763	0	0	1.11818339200185	0.690089473729585	KCNN3;CGA
Cortisol synthesis and secretion	2/65	0.547880330711442	0.99783448486763	0	0	1.10037765851719	0.662095466066987	NR4A1;CREB3L2
Chagas disease	3/102	0.54835755823096	0.99783448486763	0	0	1.05028782448137	0.63104204552485	JUN;IL12A;FOS
Butanoate metabolism	1/28	0.549397630907735	0.99783448486763	0	0	1.28386243386243	0.76894734476341	ACSM3
C-type lectin receptor signaling pathway	3/104	0.561550906887234	0.99783448486763	0	0	1.02938358351964	0.59400872711632	JUN;PLCG2;IL12A
Acute myeloid leukemia	2/67	0.564359402794421	0.99783448486763	0	0	1.0664097977157	0.610054645389229	ZBTB16;PIM2
Regulation of actin cytoskeleton	6/218	0.576046040064713	0.99783448486763	0	0	0.980469148393677	0.540795104092523	CFL2;CXCR4;PIP5K1B;ITGA6;EZR;SSH2
Prolactin signaling pathway	2/70	0.588259898075664	0.99783448486763	0	0	1.01920446174892	0.540776051915663	FOS;CGA
RIG-I-like receptor signaling pathway	2/70	0.588259898075664	0.99783448486763	0	0	1.01920446174892	0.540776051915663	CASP10;IL12A
Cytokine-cytokine receptor interaction	8/295	0.588391382293838	0.99783448486763	0	0	0.96537732104265	0.512000350685175	CD40;CXCR5;CXCR4;TNFRSF17;IL12A;CCR7;IL16;TNFRSF13C
Breast cancer	4/147	0.594049909942634	0.99783448486763	0	0	0.969027381953773	0.504661649847655	JUN;CDKN1A;IGF1;FOS
Phospholipase D signaling pathway	4/148	0.599406501433371	0.99783448486763	0	0	0.962248154797526	0.492493306457722	PLCG2;GAB1;PTK2B;PIP5K1B
Retrograde endocannabinoid signaling	4/148	0.599406501433371	0.99783448486763	0	0	0.962248154797526	0.492493306457722	CNR1;GNG7;GNB3;GNB5
Alcoholism	5/186	0.600618375264955	0.99783448486763	0	0	0.956814658770221	0.487779835174555	GNG7;CREB3L2;GNB3;GNB5;HDAC9
Melanoma	2/72	0.603645422864518	0.99783448486763	0	0	0.989982110912343	0.499711588804112	CDKN1A;IGF1
Non-small cell lung cancer	2/72	0.603645422864518	0.99783448486763	0	0	0.989982110912343	0.499711588804112	CDKN1A;PLCG2
Base excision repair	1/33	0.609231876910028	0.99783448486763	0	0	1.08297991071429	0.536677553782231	NEIL1
Fructose and mannose metabolism	1/33	0.609231876910028	0.99783448486763	0	0	1.08297991071429	0.536677553782231	GMPPB
SNARE interactions in vesicular transport	1/33	0.609231876910028	0.99783448486763	0	0	1.08297991071429	0.536677553782231	STX5
Inositol phosphate metabolism	2/73	0.611173621981423	0.99783448486763	0	0	0.975988309103278	0.4805514627226	PLCG2;PIP5K1B
Glutamatergic synapse	3/114	0.623883220828978	0.999252893590643	0	0	0.936161968420033	0.441673796899997	GNG7;GNB3;GNB5
Arrhythmogenic right ventricular cardiomyopathy	2/77	0.640193315504326	0.999252893590643	0	0	0.923744782349433	0.411976402444969	ATP2A3;ITGA6
Bacterial invasion of epithelial cells	2/77	0.640193315504326	0.999252893590643	0	0	0.923744782349433	0.411976402444969	CAV1;GAB1
Herpes simplex virus 1 infection	13/498	0.643702861916886	0.999252893590643	0	0	0.927090074497705	0.408399915400312	ZNF595;ZNF275;CD74;ZNF791;EIF2AK3;ZNF10;EIF2AK4;POU2F2;HLA-DMA;ZNF669;IL12A;HLA-DOB;HLA-DQB1
Hepatitis C	4/157	0.645656863056686	0.999252893590643	0	0	0.905222891071449	0.396023326660189	CDKN1A;CLDN14;EIF2AK3;EIF2AK4
African trypanosomiasis	1/37	0.651334990262719	0.999252893590643	0	0	0.962450396825397	0.412632505050747	IL12A
RNA degradation	2/79	0.65405200563203	0.999252893590643	0	0	0.89965848105383	0.381966572077832	BTG2;LSM7
Necroptosis	4/159	0.655442687818024	0.999252893590643	0	0	0.893449933398969	0.377432932099194	ZBP1;CHMP4C;SQSTM1;SLC25A4
Various types of N-glycan biosynthesis	1/39	0.670656405425546	0.999252893590643	0	0	0.911701127819549	0.364223084048438	ALG13
Glycine, serine and threonine metabolism	1/40	0.679912504711724	0.999252893590643	0	0	0.888278388278388	0.342689948601865	CTH
Bladder cancer	1/41	0.688908913508895	0.999252893590643	0	0	0.866026785714286	0.322721606132718	CDKN1A
Insulin secretion	2/86	0.699213668345515	0.999252893590643	0	0	0.824388789505069	0.294965407236719	CREB3L2;KCNN3
Salmonella infection	6/249	0.702512109992616	0.999252893590643	0	0	0.854009565120676	0.301544491505992	JUN;RHOH;SNX9;FOS;RHOB;HSP90B1
Oocyte meiosis	3/129	0.705457816007572	0.999252893590643	0	0	0.824074074074074	0.28752628633657	STAG3;IGF1;CPEB4
Vasopressin-regulated water reabsorption	1/44	0.714411718228961	0.999252893590643	0	0	0.805481727574751	0.270880159542535	CREB3L2
FoxO signaling pathway	3/131	0.715243022634931	0.999252893590643	0	0	0.811113911290323	0.2718309591389	CDKN1A;IGF1;KLF2
Natural killer cell mediated cytotoxicity	3/131	0.715243022634931	0.999252893590643	0	0	0.811113911290323	0.2718309591389	ICAM2;PLCG2;PTK2B
PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.717020968658439	0.999252893590643	0	0	0.795838216848642	0.264735737083502	JUN;FOS
ABC transporters	1/45	0.722440092171315	0.999252893590643	0	0	0.78713474025974	0.255913860595026	ABCB4
Other types of O-glycan biosynthesis	1/47	0.737827246452241	0.999252893590643	0	0	0.752833850931677	0.228895793694293	ST6GAL1
Pyruvate metabolism	1/47	0.737827246452241	0.999252893590643	0	0	0.752833850931677	0.228895793694293	GLO1
Autophagy	3/137	0.743089318352721	0.999252893590643	0	0	0.774554646124218	0.229995504034372	EIF2AK3;EIF2AK4;SQSTM1
TGF-beta signaling pathway	2/94	0.744725839348821	0.999252893590643	0	0	0.752391693241036	0.221759272487376	RGMB;E2F5
Axon guidance	4/182	0.754725230151678	0.999252893590643	0	0	0.77707623101285	0.21867043998159	CFL2;PLCG2;CXCR4;SSH2
Arginine and proline metabolism	1/50	0.759326051080425	0.999252893590643	0	0	0.706632653061224	0.19455293847375	PYCR1
Cysteine and methionine metabolism	1/50	0.759326051080425	0.999252893590643	0	0	0.706632653061224	0.19455293847375	CTH
Phosphatidylinositol signaling system	2/97	0.760209013869145	0.999252893590643	0	0	0.728518971848225	0.199732120201736	PLCG2;PIP5K1B
Aldosterone synthesis and secretion	2/98	0.765186528246051	0.999252893590643	0	0	0.720892963625522	0.192936654812742	NR4A1;CREB3L2
Spinocerebellar ataxia	3/143	0.768725981620948	0.999252893590643	0	0	0.741129032258064	0.19493227964845	XBP1;ATP2A3;SLC25A4
AGE-RAGE signaling pathway in diabetic complications	2/100	0.774872874613318	0.999252893590643	0	0	0.706107845642729	0.180097251573651	JUN;PLCG2
Progesterone-mediated oocyte maturation	2/100	0.774872874613318	0.999252893590643	0	0	0.706107845642729	0.180097251573651	IGF1;CPEB4
Endocrine and other factor-regulated calcium reabsorption	1/53	0.77906477196411	0.999252893590643	0	0	0.665762362637363	0.166214956463846	KLK1
Glycosaminoglycan biosynthesis	1/53	0.77906477196411	0.999252893590643	0	0	0.665762362637363	0.166214956463846	CHPF
Neutrophil extracellular trap formation	4/189	0.780154559803877	0.999252893590643	0	0	0.747401620651172	0.185552336962432	NCF1;PLCG2;SLC25A4;HDAC9
Amoebiasis	2/102	0.784208472099419	0.999252893590643	0	0	0.691914132379249	0.168190754162416	LAMA5;IL12A
Protein digestion and absorption	2/103	0.788747575806631	0.999252893590643	0	0	0.685028073469243	0.162563285021881	COL9A3;COL19A1
Regulation of lipolysis in adipocytes	1/55	0.791317630591347	0.999252893590643	0	0	0.64103835978836	0.150038769256501	CGA
T cell receptor signaling pathway	2/104	0.793202405352785	0.999252893590643	0	0	0.678277035322179	0.157141086885416	JUN;FOS
Spliceosome	3/150	0.795958509305786	0.999252893590643	0	0	0.70558115719406	0.161019418879109	LSM7;HSPA6;HSPA1B
Hedgehog signaling pathway	1/56	0.797187268654165	0.999252893590643	0	0	0.629350649350649	0.142652180840551	PTCH2
Pyrimidine metabolism	1/56	0.797187268654165	0.999252893590643	0	0	0.629350649350649	0.142652180840551	RRM2B
Glucagon signaling pathway	2/107	0.806072720665187	0.999252893590643	0	0	0.658795468097794	0.142023994247653	SIK1B;CREB3L2
Pathogenic Escherichia coli infection	4/197	0.806610973384334	0.999252893590643	0	0	0.716123570943526	0.153904832273789	JUN;CLDN14;FOS;EZR
Endometrial cancer	1/58	0.808436729392548	0.999252893590643	0	0	0.607205513784461	0.129123988997582	CDKN1A
Cushing syndrome	3/155	0.813729814959798	0.999252893590643	0	0	0.682194397283531	0.140618609986793	NR4A1;CDKN1A;CREB3L2
VEGF signaling pathway	1/59	0.813825662031515	0.999252893590643	0	0	0.596705665024631	0.122926803178607	PLCG2
Ribosome	3/158	0.823751062592501	0.999252893590643	0	0	0.66888657648283	0.129688346920272	RPL18A;RPS8;RPS5
Glycerolipid metabolism	1/61	0.824153759199433	0.999252893590643	0	0	0.576755952380952	0.111543543137608	PLPP5
Parkinson disease	5/249	0.831167663486968	0.999252893590643	0	0	0.707446338011558	0.130823625053006	XBP1;DUSP1;DDIT3;EIF2AK3;SLC25A4
Cytosolic DNA-sensing pathway	1/63	0.833909859142184	0.999252893590643	0	0	0.55809331797235	0.101366469825712	ZBP1
Lysine degradation	1/63	0.833909859142184	0.999252893590643	0	0	0.55809331797235	0.101366469825712	PRDM2
Rap1 signaling pathway	4/210	0.844028233404392	0.999252893590643	0	0	0.670478116121385	0.1136925269718	CNR1;IGF1;RASGRP2;SIPA1L3
Neuroactive ligand-receptor interaction	7/341	0.845992054881959	0.999252893590643	0	0	0.722751248405716	0.120876757179734	CYSLTR1;P2RX5;THRB;CNR1;P2RX1;OXT;CGA
Hepatocellular carcinoma	3/168	0.853891200838753	0.999252893590643	0	0	0.628022157054415	0.0991970372155884	CDKN1A;PLCG2;GAB1
AMPK signaling pathway	2/120	0.853952384882668	0.999252893590643	0	0	0.585822140020012	0.09248950699707	CREB3L2;IGF1
Central carbon metabolism in cancer	1/70	0.863992827273627	0.999252893590643	0	0	0.501293995859213	0.0732845762949447	PDK1
Cell cycle	2/124	0.866358961938105	0.999252893590643	0	0	0.566497551247837	0.0812674447275439	CDKN1A;E2F5
Purine metabolism	2/129	0.88050603844795	0.999252893590643	0	0	0.544053639091178	0.0692354462726686	RRM2B;PDE4B
Chronic myeloid leukemia	1/76	0.885408391851309	0.999252893590643	0	0	0.461047619047619	0.0561123909375738	CDKN1A
Gastric acid secretion	1/76	0.885408391851309	0.999252893590643	0	0	0.461047619047619	0.0561123909375738	EZR
Pancreatic cancer	1/76	0.885408391851309	0.999252893590643	0	0	0.461047619047619	0.0561123909375738	CDKN1A
Chemical carcinogenesis	4/239	0.905991970839642	0.999252893590643	0	0	0.586852056992246	0.0579368726053169	JUN;CREB3L2;FOS;HSP90B1
Ubiquitin mediated proteolysis	2/140	0.90689119918995	0.999252893590643	0	0	0.500401856316922	0.0489056709672128	SYVN1;RHOBTB2
Cardiac muscle contraction	1/87	0.916309155038862	0.999252893590643	0	0	0.401848006644518	0.0351221047891395	ATP2A3
Bile secretion	1/90	0.923185279332707	0.999252893590643	0	0	0.388242375601926	0.0310303994537901	ABCB4
Gastric cancer	2/149	0.924318882965378	0.999252893590643	0	0	0.469545957918051	0.0369524007840148	CDKN1A;GAB1
Adrenergic signaling in cardiomyocytes	2/150	0.926053475497925	0.999252893590643	0	0	0.466349175651501	0.0358264812666611	CREB3L2;ATP2A3
Diabetic cardiomyopathy	3/203	0.926744003280757	0.999252893590643	0	0	0.517177419354839	0.0393457759587339	NCF1;ATP2A3;SLC25A4
Glycerophospholipid metabolism	1/98	0.938887815248649	0.999252893590643	0	0	0.356075110456554	0.022453839909691	PLPP5
mRNA surveillance pathway	1/98	0.938887815248649	0.999252893590643	0	0	0.356075110456554	0.022453839909691	RNGTT
Melanogenesis	1/101	0.943911497006675	0.999252893590643	0	0	0.345339285714286	0.0199339748342241	CREB3L2
JAK-STAT signaling pathway	2/162	0.944143136055694	0.999252893590643	0	0	0.431104651162791	0.024778816359955	CDKN1A;IL12A
Pancreatic secretion	1/102	0.94549270553068	0.999252893590643	0	0	0.341902404526167	0.0191633240604815	ATP2A3
Wnt signaling pathway	2/166	0.949175463376169	0.999252893590643	0	0	0.420502639731227	0.0219340924050388	JUN;TLE1
Drug metabolism	1/108	0.954087985773446	0.999252893590643	0	0	0.322630173564753	0.0151634192600949	RRM2B
Insulin resistance	1/108	0.954087985773446	0.999252893590643	0	0	0.322630173564753	0.0151634192600949	CREB3L2
Human papillomavirus infection	5/331	0.957257178467864	0.999252893590643	0	0	0.527237719027232	0.0230314252448012	LAMA5;CDKN1A;CREB3L2;COL9A3;ITGA6
NOD-like receptor signaling pathway	2/181	0.964458154117256	0.999252893590643	0	0	0.38496517124554	0.0139314405495838	JUN;TXNIP
Sphingolipid signaling pathway	1/119	0.966485415298404	0.999252893590643	0	0	0.292388014527845	0.00996723569080176	CERS4
Shigellosis	3/246	0.97039098949034	0.999252893590643	0	0	0.424709057922917	0.0127651432542124	JUN;PLCG2;SQSTM1
Oxidative phosphorylation	1/133	0.97755314165167	0.999252893590643	0	0	0.261187770562771	0.00592964768039022	LHPP
Alzheimer disease	5/369	0.978927421042905	0.999252893590643	0	0	0.471257609297178	0.0100367385340467	XBP1;DDIT3;EIF2AK3;ATP2A3;SLC25A4
Insulin signaling pathway	1/137	0.979983071411982	0.999252893590643	0	0	0.253453256302521	0.00512482016270756	MKNK2
Pathways of neurodegeneration	7/475	0.98095598341146	0.999252893590643	0	0	0.512191829430097	0.00984826547346722	XBP1;DDIT3;EIF2AK3;ATP2A3;IFT57;SQSTM1;SLC25A4
Signaling pathways regulating pluripotency of stem cells	1/143	0.983144460635889	0.999252893590643	0	0	0.242668511066398	0.00412517314854923	IGF1
mTOR signaling pathway	1/154	0.987702359491817	0.999252893590643	0	0	0.225093370681606	0.0027852788518988	IGF1
Thermogenesis	2/232	0.989829741307008	0.999252893590643	0	0	0.298809986777631	0.00305453402956201	CNR1;CREB3L2
Hippo signaling pathway	1/163	0.990499520558483	0.999252893590643	0	0	0.21248897707231	0.00202839786402222	RASSF6
Amyotrophic lateral sclerosis	4/364	0.992190250758798	0.999252893590643	0	0	0.380590464791542	0.00298398340082142	XBP1;DDIT3;EIF2AK3;SQSTM1
Huntington disease	3/306	0.99225994894007	0.999252893590643	0	0	0.339543631782533	0.00263830859130171	CREB3L2;IFT57;SLC25A4
MicroRNAs in cancer	3/310	0.992940373515084	0.999252893590643	0	0	0.335049560435712	0.00237371340908355	CDKN1A;PLCG2;EZR
RNA transport	1/186	0.995089339867349	0.999252893590643	0	0	0.185849420849421	0.000914891545407713	EIF1AY
Olfactory transduction	1/440	0.99999325569455	0.99999325569455	0	0	0.0772860397006183	5.21242416507253e-07	GNG7
